These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3564508)

  • 1. Women and preventive health care: an exploratory study of the use of Pap smears in a potentially high-risk Appalachian population.
    Fisher S; Page AL
    Women Health; 1986; 11(3-4):83-99. PubMed ID: 3564508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's experiences of cervical cellular changes: an unintentional transition from health to liminality?
    Forss A; Tishelman C; Widmark C; Sachs L
    Sociol Health Illn; 2004 Apr; 26(3):306-25. PubMed ID: 15043601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH; Tsai WC; Kung PT
    Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology in vulnerable pregnant women.
    Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
    J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening among Latinas recently immigrated to the United States.
    Fernández-Esquer ME; Cardenas-Turanzas M
    Prev Med; 2004 May; 38(5):529-35. PubMed ID: 15066355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia?
    Hislop TG; Clarke HF; Deschamps M; Joseph R; Band PR; Smith J; Le N; Atleo R
    Can Fam Physician; 1996 Sep; 42():1701-8. PubMed ID: 8828873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.